HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC's Claimed Authority To Chase Permanent Injunctions, Monetary Relief May Lack Substantiation

Executive Summary

The Federal Trade Commission has long held that Section 13(b) of the FTC Act authorizes the agency to seek permanent injunctions against, and monetary relief from, alleged violators of consumer protection provisions. But that understanding is being put to the test, and cracks are beginning to show, attorneys say.

You may also be interested in...



FTC Scores Preliminary Injunction Against ‘Free Trial’ Scam, Another Case That Could Test Agency Authorities

The US Federal Trade Commission’s authority to secure permanent injunctions against defendants and obtain penalties for misconduct under FTC Act consumer protection provisions has taken hits in federal appeals courts of late. But for now, it is business as usual for the FTC in California federal court where it just won a preliminary injunction against alleged beauty and dietary supplement “free trial” fraudsters.

FTC Predicted ‘Parade Of Horribles’ If Third Circuit Were To Rule As It Just Did

The Federal Trade Commission is accustomed to seeking permanent injunctions (and monetary penalties) from companies for past violations under Section 13(b) of the FTC Act, which it contends is an invaluable deterrent to bad behavior. However, the Third Circuit says FTC’s interpretation of the section’s provisions is an untenable stretch of statutory language.

Health, Beauty And Wellness News: FTC, FDA Enforcement, Noosh In Vitamin Shoppe, GNC Tests Store Features

Dr. Schulze's warned on cancer claims; Nutrition 21 ingredients in BPI Sports, Olympus Labs supplements; GNC tests 'experiential' store features, helps promote ZanthSyn; Noosh Almond Protein in Vitamin Shoppe; and FTC says no more, Nobetes.

Related Content

Topics

UsernamePublicRestriction

Register

RS148478

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel